Price Alert

XTL Biopharmaceuticals Lt... (XTLB)

NASDAQ: XTLB · Real-Time Price · USD

1.33

-0.09 (-6.34%)

At close: Aug 15, 2025, 1:40 PM

1.41

6.02%

After-hours: Aug 15, 2025, 04:00 PM EDT

XTL Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	371K	820K	594K	1.07M	1.4M	1.46M	1.59M	1.9M	2.09M	2.23M	2.35M	2.79M	2.97M	3.01M	2.92M	3.39M
Short-Term Investments	772K	900K	992K	1.27M	605K	749K	794K	972K	1.63M	2.16M	2.81M	n/a	3.16M	n/a	3.38M	n/a
Long-Term Investments	14K	n/a	n/a	n/a	-604.39K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	604.39K	n/a	n/a	n/a	n/a	n/a	n/a	381K	n/a	382K	n/a	382K
Receivables	99K	140K	304K	150K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	47K	n/a	128K	n/a	11K	n/a	n/a	n/a	14K	n/a	n/a	3.45M	16K	3.46M	n/a	3.54M
Total Current Assets	1.34M	1.99M	2.02M	2.55M	2.05M	2.28M	2.5M	2.94M	3.81M	4.52M	5.38M	6.24M	6.24M	6.47M	6.57M	6.93M
Property-Plant & Equipment	187K	217K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	n/a	1K	n/a	2K	n/a
Goodwill & Intangibles	7.01M	7.08M	380K	380K	380K	380K	380K	380K	380K	380K	380K	n/a	380K	n/a	380K	n/a
Total Long-Term Assets	7.21M	7.29M	380K	380K	380K	380K	380K	380K	380K	380K	381K	381K	381K	382K	382K	382K
Total Assets	8.55M	9.28M	2.4M	2.93M	2.43M	2.66M	2.88M	3.32M	4.19M	4.9M	5.76M	6.62M	6.62M	6.86M	6.95M	7.31M
Account Payables	196K	554K	165K	223K	1K	162K	163K	241K	2K	153K	172K	n/a	2K	185K	258K	n/a
Deferred Revenue	18K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	138K	168K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.33M	1.75M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	2.21M	2.47M	165K	223K	206K	162K	163K	241K	187K	153K	172K	260K	231K	185K	258K	251K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	689K	765K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22K	517K	1.05M	3.59M	3.41M	2.69M
Total Long-Term Liabilities	908K	1.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22K	517K	1.05M	3.59M	3.41M	2.69M
Total Liabilities	3.12M	3.56M	165K	223K	206K	162K	163K	241K	187K	153K	194K	777K	1.28M	3.78M	3.67M	2.94M
Total Debt	138K	168K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	23.14M	23.14M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	5.84K	14.12M	3.08K	13.6M	4.37K
Retained Earnings	-159.01M	-158.77M	-158.23M	-157.76M	-158.25M	-157.97M	-157.75M	-157.38M	-156.47M	-155.72M	-154.9M	n/a	-155.13M	n/a	-156.45M	n/a
Comprehensive Income	20K	20K	20K	20K	20K	20K	20K	20K	20K	20K	20K	n/a	20K	n/a	20K	n/a
Shareholders Equity	5.43M	5.72M	2.23M	2.71M	2.22M	2.5M	2.72M	3.08M	4M	4.74M	5.56M	5.84M	5.33M	3.08M	3.28M	4.37M
Total Investments	786K	900K	992K	1.27M	605.00	749K	794K	972K	1.63M	2.16M	2.81M	n/a	3.16M	n/a	3.38M	n/a